Loading...
Loading...
Basel Medical Group Ltd
Basel Medical Group Ltd. Spoken Alpha tracks BMGL's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks BMGL's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 8/10 quarters with 90% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 5 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for BMGL.
curl https://api.spokenalpha.com/v1/companies/BMGL| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $2.67 | $2.71 | -1.5% | +2.8% | +5.8% |
| Q4 FY2026 | $2.81 | $2.70 | +4.0% | +0.3% | -1.4% |
| Q3 FY2026 | $3.02 | $2.85 | +6.0% | +2.6% | +3.5% |
| Q2 FY2026 | $3.09 | $2.83 | +9.3% | -0.9% | -1.7% |
| Q1 FY2025 | $3.09 | $2.91 | +6.3% | +1.3% | +0.3% |
| Q4 FY2025 | $3.18 | $2.95 | +7.9% | +1.7% | +3.0% |
| Q3 FY2025 | $2.98 | $2.82 | +5.7% | +9.8% | +12.6% |
| Q2 FY2025 | $2.87 | $2.93 | -1.9% | +0.9% | -1.4% |
| Q1 FY2024 | $3.10 | $2.94 | +5.6% | +1.3% | +1.7% |
| Q4 FY2024 | $3.15 | $2.96 | +6.5% | +6.8% | +9.5% |